GG 216 (Amitriptyline and perphenazine 25 mg / 4 mg)
Pill imprint GG 216 has been identified as Amitriptyline and perphenazine 25 mg / 4 mg.
Amitriptyline/perphenazine is used in the treatment of anxiety; depression; agitation and belongs to the drug class psychotherapeutic combinations. FDA has not classified the drug for risk during pregnancy. Amitriptyline/perphenazine 25 mg / 4 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about amitriptyline/perphenazine
- Amitriptyline and perphenazine
- Perphenazine and amitriptyline (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.